{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:15:37Z","timestamp":1792887337316,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejpb.2026.115204","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:44:35Z","timestamp":1785944675000},"page":"115204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Intranasal Pacritinib-loaded nanoemulsion for Glioblastoma management: In Vitro, ex Vivo, 3D spheroid and In vivo brain biodistribution studies"],"prefix":"10.1016","volume":"227","author":[{"given":"Anupama","family":"Sikder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha Naresh","family":"Katarpawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Phatale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Vambhurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj","family":"Wagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giriraj","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol G.","family":"Dikundwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0723-4363","authenticated-orcid":false,"given":"Saurabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115204_b0005","doi-asserted-by":"crossref","unstructured":"K. Kr\u00f3likowska, K. B\u0142aszczak, S. \u0141awicki, M. Zajkowska, M. Gudowska-Sawczuk, Glioblastoma\u2014A Contemporary Overview of Epidemiology, Classification, Pathogenesis, Diagnosis, and Treatment: A Review Article, International Journal of Molecular Sciences 2025, Vol. 26, Page 12162 26 (2025) 12162. Doi: 10.3390\/IJMS262412162.","DOI":"10.3390\/ijms262412162"},{"key":"10.1016\/j.ejpb.2026.115204_b0010","article-title":"Deciphering convection enhanced delivery: a paradigm shift for circumventing glioblastoma multiforme","volume":"103","author":"Sikder","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115204_b0015","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/10717544.2019.1616235","article-title":"A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain\/brain tumor barriers for glioblastoma treatment","volume":"26","author":"Wang","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115204_b0020","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1517\/17425247.2013.790887","article-title":"Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood\u2013brain barrier: an excellent platform for brain targeting","volume":"10","author":"Pardeshi","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115204_b0025","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/17425247.2025.2489553","article-title":"The nasal route for nose-to-brain drug delivery: advanced nasal formulations for CNS disorders","volume":"22","author":"Papakyriakopoulou","year":"2025","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115204_b0030","doi-asserted-by":"crossref","unstructured":"M. Opazo-Navarrete, E. Morales, S. Kiran Misra, K. Pathak, Nose-to-Brain Targeting via Nanoemulsion: Significance and Evidence, Colloids and Interfaces 2023, Vol. 7, Page 23 7 (2023) 23. Doi: 10.3390\/COLLOIDS7010023.","DOI":"10.3390\/colloids7010023"},{"key":"10.1016\/j.ejpb.2026.115204_b0035","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.2147\/IJN.S488545","article-title":"Nanoemulsions based Therapeutic strategies: Enhancing Targeted Drug delivery against Breast Cancer Cells","volume":"20","author":"Izadiyan","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2026.115204_b0040","doi-asserted-by":"crossref","unstructured":"A. Ou, M. Ott, D. Fang, A.B. Heimberger, The Role and Therapeutic Targeting of JAK\/STAT Signaling in Glioblastoma, Cancers 2021, Vol. 13, Page 437 13 (2021) 437. Doi: 10.3390\/CANCERS13030437.","DOI":"10.3390\/cancers13030437"},{"key":"10.1016\/j.ejpb.2026.115204_b0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/JEP.S110702","article-title":"Comprehensive kinase profile of pacritinib, a nonmyelosuppressive janus kinase 2 inhibitor","volume":"8","author":"Singer","year":"2016","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115204_b0050","doi-asserted-by":"crossref","unstructured":"M.T. Gebru, H.G. Wang, Therapeutic targeting of FLT3and associated drug resistance in acute myeloid leukemia, Journal of Hematology & Oncology 2020 13:1 13 (2020) 155-. Doi: 10.1186\/S13045-020-00992-1.","DOI":"10.1186\/s13045-020-00992-1"},{"key":"10.1016\/j.ejpb.2026.115204_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189670","article-title":"The JAK2\/STAT3 inhibitor pacritinib effectively inhibits patient-derived GBM brain tumor initiating cells in vitro and when used in combination with temozolomide increases survival in an orthotopic xenograft model","volume":"12","author":"Jensen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2026.115204_b0060","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3390\/jcm8070959","article-title":"Preclinical evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages","volume":"8","author":"Chuang","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejpb.2026.115204_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2026.174331","article-title":"Selective temozolomide spherulite growth based on nanoconfined crystal engineering for intranasal brain delivery","volume":"531","author":"Liu","year":"2026","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ejpb.2026.115204_b0070","article-title":"QbD-based intranasal pH-sensitive Ibrutinib liposomes for glioblastoma management: in vitro, ex vivo, and in vivo pharmacokinetics and brain distribution assessment","author":"Sikder","year":"2026","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics 225"},{"key":"10.1016\/j.ejpb.2026.115204_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120250","article-title":"Nose-to-brain delivery of disulfiram nanoemulsion in situ gel formulation for glioblastoma targeting therapy","volume":"597","author":"Qu","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115204_b0080","doi-asserted-by":"crossref","unstructured":"Vikram, A. Muheem, S. Kumar, D. Chaudhary, M. Waseem, S. Baboota, J. Ali, Co-Delivery of Temozolomide and Quercetin via Nanoemulsion for Glioblastoma Therapy: From In-Silico to In-Vivo Evaluation, Journal of Cluster Science 2025 36:6 36 (2025) 199-. Doi: 10.1007\/S10876-025-02916-W.","DOI":"10.1007\/s10876-025-02916-w"},{"key":"10.1016\/j.ejpb.2026.115204_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2026.214835","article-title":"Nose-to-brain delivery of berberine-loaded nanoemulsion: Amelioration of brain targeting, behavioral, pharmacokinetic, and biodistribution insights for Alzheimer\u2019s intervention","volume":"184","author":"Negi","year":"2026","journal-title":"Biomaterials Advances"},{"key":"10.1016\/j.ejpb.2026.115204_b0090","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jconrel.2023.01.070","article-title":"Nasal administration of a temozolomide-loaded thermoresponsive nanoemulsion reduces tumor growth in a preclinical glioblastoma model","volume":"355","author":"Michels","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115204_b0095","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.2147\/IJN.S308057","article-title":"Intratumoral administration of thermosensitive hydrogel co-loaded with norcantharidin nanoparticles and doxorubicin for the treatment of hepatocellular carcinoma","volume":"16","author":"Gao","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2026.115204_b0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/08982104.2024.2389969","article-title":"Effect of size and pH-sensitivity of liposomes on cellular uptake pathways and pharmacokinetics of encapsulated gemcitabine","volume":"35","author":"Tang","year":"2025","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2026.115204_b0105","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.2147\/IJN.S132472","article-title":"Neuroprotection against apoptosis of SK-N-MC cells using RMP-7- and lactoferrin-grafted liposomes carrying quercetin","volume":"12","author":"Kuo","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2026.115204_b0110","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijpharm.2018.03.055","article-title":"Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro","volume":"543","author":"Colombo","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115204_b0115","article-title":"Development and optimization of chitosan coated nanoemulgel of telmisartan for intranasal delivery: a comparative study","volume":"62","author":"Chin","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115204_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124376","article-title":"Therapeutic potential of limonene-based syringic acid nanoemulsion: Enhanced ex-vivo cutaneous deposition and clinical anti-psoriatic efficacy","volume":"660","author":"Assalem","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115204_b0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpharm.2019.04.076","article-title":"Design and development of letrozole nanoemulsion: a comparative evaluation of brain targeted nanoemulsion with free letrozole against status epilepticus and neurodegeneration in mice","volume":"565","author":"Iqbal","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115204_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodcont.2025.111393","article-title":"Formulation optimization, antimicrobial mechanisms, and application of Amomum tsao-ko essential oil nanoemulsion","volume":"176","author":"Zhang","year":"2025","journal-title":"Food Control"},{"key":"10.1016\/j.ejpb.2026.115204_b0135","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.dyepig.2011.03.011","article-title":"A comparative study of a novel lipophilic phthalocyanine incorporated into nanoemulsion formulations: Photophysics, size, solubility and thermodynamic stability","volume":"91","author":"Garc\u00eda Vior","year":"2011","journal-title":"Dyes Pigm."},{"key":"10.1016\/j.ejpb.2026.115204_b0140","doi-asserted-by":"crossref","unstructured":"P. Kuili, V. Karmakar, A. Chatterjee, W.M. Lim, B. Gorain, Oleanolic Acid-loaded Chitosan-coated Nanoemulsion for Safe Nose-to-brain Delivery for Insulin-resistant Memory Decline, BioNanoScience 2026 16:3 16 (2026) 226-. Doi: 10.1007\/S12668-026-02478-9.","DOI":"10.1007\/s12668-026-02478-9"},{"key":"10.1016\/j.ejpb.2026.115204_b0145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3390\/ijms20020399","article-title":"Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt\/mTOR Pathway in Cultured Glioblastoma Cells","volume":"20","author":"Maiti","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115204_b0150","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1080\/03639045.2025.2509861","article-title":"Combating breast cancer-associated metastasis using paclitaxel and tranilast-loaded human serum albumin nanoparticles","volume":"51","author":"Jain","year":"2025","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2026.115204_b0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/jidsymp.2009.12","article-title":"Reactive oxygen species in HaCaT keratinocytes after UVB irradiation are triggered by intracellular Ca2+ levels","volume":"14","author":"Masaki","year":"2009","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"10.1016\/j.ejpb.2026.115204_b0160","doi-asserted-by":"crossref","DOI":"10.1007\/s10876-026-03026-x","article-title":"Quality by Design Manoeuvred Cabazitaxel-Loaded Polycaprolactone Nanoparticles for Management of Melanoma: Development, Optimization, In Silico Modeling and In Vitro Studies","volume":"37","author":"Wagh","year":"2026","journal-title":"J. Clust. Sci."},{"key":"10.1016\/j.ejpb.2026.115204_b0165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/cyto.a.10059","article-title":"Sensitive and Reliable JC-1 and TOTO-3 double Staining to Assess Mitochondrial Transmembrane potential and Plasma Membrane Integrity: interest for Cell Death Investigations","volume":"54","author":"Zuliani","year":"2003","journal-title":"Cytometry A"},{"key":"10.1016\/j.ejpb.2026.115204_b0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/03639045.2025.2453533","article-title":"Docetaxel and niclosamide-loaded nanofiber systems for improved chemo-therapeutic activity and resistance reversal in prostate cancer, Drug Dev","volume":"51","author":"Shah","year":"2025","journal-title":"Ind. Pharm."},{"key":"10.1016\/j.ejpb.2026.115204_b0175","doi-asserted-by":"crossref","unstructured":"G. Pandey, P. Famta, S. Shah, R. Kumar, S. Wagh, G. Vambhurkar, A. Sharma, A. Sharma, S. Shinde, G. Singh, S. Chandankar, A. Dalal, N.P. Kalia, A. Asthana, S. Srivastava, Disulfiram-Encapsulated Poly(caprolactone) Nanofiber Scaffolds for Oral Squamous Cell Carcinoma Management, BioNanoScience 2025 15:4 15 (2025) 530-. Doi: 10.1007\/S12668-025-02153-5.","DOI":"10.1007\/s12668-025-02153-5"},{"key":"10.1016\/j.ejpb.2026.115204_b0180","doi-asserted-by":"crossref","unstructured":"A. Ou, M. Ott, D. Fang, A.B. Heimberger, The Role and Therapeutic Targeting of JAK\/STAT Signaling in Glioblastoma, Cancers 2021, Vol. 13, Page 437 13 (2021) 437. Doi: 10.3390\/CANCERS13030437.","DOI":"10.3390\/cancers13030437"},{"key":"10.1016\/j.ejpb.2026.115204_b0185","doi-asserted-by":"crossref","unstructured":"S. Shaikh, P.S. Chary, O. Khan, N.K. Mehra, Development and evaluation of nilotinib-loaded Bovine Serum Albumin nanoparticles: In-vitro and in-silico insights, ElsevierS Shaikh, PS Chary, O Khan, NK MehraInternational Journal of Biological Macromolecules, 2025\u2022Elsevier 308 (2025). Doi: 10.1016\/j.ijbiomac.2025.142185.","DOI":"10.1016\/j.ijbiomac.2025.142185"},{"key":"10.1016\/j.ejpb.2026.115204_b0190","first-page":"2239","article-title":"Role of three-dimensional cell culture in therapeutics and diagnostics: an updated review, Drug Deliv","volume":"13","author":"Biju","year":"2023","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115204_b0195","doi-asserted-by":"crossref","unstructured":"K. Duval, H. Grover, L.H. Han, Y. Mou, A.F. Pegoraro, J. Fredberg, Z. Chen, Modeling Physiological Events in 2D vs. 3D Cell Culture, Doi: 10.1152\/Physiol.00036.2016 32 (2017) 266\u2013277. Doi: 10.1152\/PHYSIOL.00036.2016.","DOI":"10.1152\/physiol.00036.2016"},{"key":"10.1016\/j.ejpb.2026.115204_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1491669","article-title":"Perspective of 3D culture in medicine: transforming disease research and therapeutic applications","volume":"12","author":"Park","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ejpb.2026.115204_b0205","doi-asserted-by":"crossref","unstructured":"F. Fontana, M. Marzagalli, M. Sommariva, N. Gagliano, P. Limonta, In Vitro 3D Cultures to Model the Tumor Microenvironment, Cancers 2021, Vol. 13, Page 2970 13 (2021) 2970. Doi: 10.3390\/CANCERS13122970.","DOI":"10.3390\/cancers13122970"},{"key":"10.1016\/j.ejpb.2026.115204_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140316","article-title":"Fabrication and characterization of teriflunomide-loaded chondroitin sulfate hybridized zein nanoparticles for the management of triple negative breast cancer","volume":"300","author":"Rajana","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2026.115204_b0215","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1021\/acsabm.5c01473","article-title":"Strategic Nanosuspension of Darolutamide for Enhanced Dissolution, Bioavailability, and Potentiated Prostate Cancer Treatment: Insights from Multiscale Computational Modeling","volume":"8","author":"Pardhi","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ejpb.2026.115204_b0220","doi-asserted-by":"crossref","unstructured":"S. Shah, P. Famta, R. Kumar, G. Vambhurkar, G. Pandey, A. Shinde, S.B. Prasad, A. Sharma, A. Sharma, S. Kanaujiya, D.K. Arya, T. Kolipaka, S. Wagh, P.S. Rajinikanth, S. Srivastava, QbD Manoeuvred Niclosamide Laden Polylactic-co-Glycolic Acid Nanoparticles-Impregnated Gelatin Nanofibers for the Management of Oral Carcinoma, BioNanoScience 2025 15:2 15 (2025) 221-. Doi: 10.1007\/S12668-025-01833-6.","DOI":"10.1007\/s12668-025-01833-6"},{"key":"10.1016\/j.ejpb.2026.115204_b0225","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.actbio.2020.06.019","article-title":"Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy","volume":"113","author":"Barve","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2026.115204_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2026.115955","article-title":"Nose-to-brain delivery of riluzole-loaded nanoemulsion in a controlled cortical impact-induced traumatic brain injury: Insights from In vitro, Ex vivo, and In vivo studies","volume":"267","author":"Amulya","year":"2026","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejpb.2026.115204_b0235","doi-asserted-by":"crossref","unstructured":"S. Nene, G. Devabattula, G. Vambhurkar, K.P. Tryphena, P.K. Singh, D.K. Khatri, C. Godugu, S. Srivastava, High mobility group box 1 cytokine targeted topical delivery of resveratrol embedded nanoemulgel for the management of atopic dermatitis, Drug Delivery and Translational Research 2024 15:1 15 (2024) 134\u2013157. Doi: 10.1007\/S13346-024-01565-2.","DOI":"10.1007\/s13346-024-01565-2"},{"key":"10.1016\/j.ejpb.2026.115204_b0240","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/08982104.2023.2214619","article-title":"Nose to brain delivery of naringin loaded transniosomes for epilepsy: formulation, characterisation, blood-brain distribution and invivo pharmacodynamic evaluation","volume":"34","author":"Gupta","year":"2024","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2026.115204_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121683","article-title":"Amelioration of oxidative stress utilizing nanoemulsion loaded with bromocriptine and glutathione for the management of Parkinson\u2019s disease","volume":"618","author":"Usama Ashhar","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115204_b0250","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jssc.202100452","article-title":"Homogeneous liquid\u2013liquid extraction as an alternative sample preparation technique for biomedical analysis","volume":"45","author":"Hammad","year":"2022","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.ejpb.2026.115204_b0255","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijpharm.2017.07.030","article-title":"Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion","volume":"529","author":"Abdou","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115204_b0260","doi-asserted-by":"crossref","unstructured":"S.N. Katarpawar, K.J. Susanna, V.V.S.P.K. Rayala, P. Radhakrishnanand, Simultaneous Determination and Drug\u2013Drug Interaction Study of Losartan and Aprepitant Through Pharmacokinetic Approach in Rat Plasma by UHPLC\u2013QqQ-MS\/MS, Chromatographia 2024 87:6 87 (2024) 419\u2013432. Doi: 10.1007\/S10337-024-04332-0.","DOI":"10.1007\/s10337-024-04332-0"},{"key":"10.1016\/j.ejpb.2026.115204_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119499","article-title":"Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting","volume":"586","author":"Kumbhar","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115204_b0270","unstructured":"Pacritinib, (n.d.). https:\/\/go.drugbank.com\/drugs\/DB11697 (accessed July 15, 2026)."},{"key":"10.1016\/j.ejpb.2026.115204_b0275","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1055\/a-2658-2217","article-title":"Volatile oils from Natural Plants: Promising Penetration Enhancers for Biological Barriers","volume":"7","author":"Ma","year":"2025","journal-title":"Pharmaceutical Fronts"},{"key":"10.1016\/j.ejpb.2026.115204_b0280","doi-asserted-by":"crossref","unstructured":"M.M. Melk, A.K. Abdallah, F.A. Abdelkader, A.A. Hassan, A.S. Youssef, E. Gomaa, E.M. Basiouny, M.H. Haroun, A. Elshanawany, A.S.A. Shaat, M.A.O. Saad, H.A. Aburaida, H.H. Shaath, M. Salem, M.E. Youssef, S.T. Alhalayqa, A. Sayed, L.M.S. Mohamed, I.E. ElSheikh, F.A. Mohamed, N.A. El-Sherif, H. Adel, A. Mostafa, M.M. Hamouda, M.A. Almayouf, R.S. Al-Habeeb, W.M. Al-Bishri, H.M. El-Shora, N.E. Al-Hazmi, M.A. Mosleh, A.S. Doghish, G.S. El-Sayyad, Current Developments in Green Nanoemulsion Technology: Biomass-Assisted Synthesis, Characterization, and Implications for the Environment and Biomedicine, BioNanoScience 2026 16:5 16 (2026) 344-. Doi: 10.1007\/S12668-026-02505-9.","DOI":"10.1007\/s12668-026-02505-9"},{"key":"10.1016\/j.ejpb.2026.115204_b0285","first-page":"384","article-title":"Investigation of Factors Influencing Formation of Nanoemulsion by Spontaneous Emulsification: Impact on Droplet size","volume":"9","author":"Algahtani","year":"2022","journal-title":"Polydispersity Index, and Stability, Bioengineering"},{"key":"10.1016\/j.ejpb.2026.115204_b0290","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jsps.2021.09.016","article-title":"Nanoemulsion and Solid Nanoemulsion for improving Oral delivery of a Breast Cancer Drug: Formulation, Evaluation, and a Comparison Study","volume":"29","author":"Tarik Alhamdany","year":"2021","journal-title":"Saudi Pharmaceutical Journal"},{"key":"10.1016\/j.ejpb.2026.115204_b0295","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.colsurfa.2016.09.074","article-title":"Assessing the stability of Tween 80-based O\/W emulsions with cyclic voltammetry and electrical impedance spectroscopy","volume":"511","author":"Roldan-Cruz","year":"2016","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"10.1016\/j.ejpb.2026.115204_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121050","article-title":"Nose-to-brain delivery of amisulpride-loaded lipid-based poloxamer-gellan gum nanoemulgel: In vitro and in vivo pharmacological studies","volume":"607","author":"Gadhave","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115204_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124376","article-title":"Therapeutic potential of limonene-based syringic acid nanoemulsion: Enhanced ex-vivo cutaneous deposition and clinical anti-psoriatic efficacy","volume":"660","author":"Assalem","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115204_b0310","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jddst.2019.02.013","article-title":"Intranasal teriflunomide microemulsion: an improved chemotherapeutic approach in glioblastoma","volume":"51","author":"Gadhave","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115204_b0315","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1546798","article-title":"Fabrication of a Thermosensitive In Situ Gel Nanoemulsion for Nose to Brain delivery of Temozolomide","volume":"2021","author":"Bayanati","year":"2021","journal-title":"J. Nanomater."},{"key":"10.1016\/j.ejpb.2026.115204_b0320","article-title":"Targeted delivery of PTX by lactoferrin-modified nanoemulsions for the treatment of glioblastoma","volume":"10","author":"Huang","year":"2025","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.ejpb.2026.115204_b0325","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/antiox12020437","article-title":"Nanoemulsion Composed of \u03b1-Tocopherol Succinate and Dequalinium shows Mitochondria-Targeting and Anticancer Effects","volume":"12","author":"Thuy","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejpb.2026.115204_b0330","article-title":"Fluorinated charge-reversible phthalocyanine nanoemulsions for glioma-targeted dual-modal imaging and self-oxygenated phototherapy","volume":"38","author":"Wu","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.ejpb.2026.115204_b0335","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1016\/j.ijbiomac.2020.08.084","article-title":"Stabilization of Zataria essential oil with pectin-based nanoemulsion for enhanced cytotoxicity in monolayer and spheroid drug-resistant breast cancer cell cultures and deciphering its binding mode with gDNA","volume":"164","author":"Salehi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2026.115204_b0340","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/gels9020130","article-title":"Intranasal Administration of Dolutegravir-Loaded Nanoemulsion-Based In Situ Gel for Enhanced Bioavailability and Direct Brain Targeting","volume":"9","author":"Nair","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.ejpb.2026.115204_b0345","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.jsps.2021.11.006","article-title":"Intranasal delivery of Clozapine using nanoemulsion-based in-situ gels: an approach for bioavailability enhancement","volume":"29","author":"Abdulla","year":"2021","journal-title":"Saudi Pharmaceutical Journal"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:14:56Z","timestamp":1788174896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126002250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":69,"alternative-id":["S0939641126002250"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115204","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal Pacritinib-loaded nanoemulsion for Glioblastoma management: In Vitro, ex Vivo, 3D spheroid and In vivo brain biodistribution studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115204"}}